SKYSTAR BIO-PHARMACEUTICAL CO Finite-Lived Intangible Asset, Expected Amortization, Year Five
SKYSTAR BIO-PHARMACEUTICAL CO had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $248.35 thousand as of 2013-12-31, per its 10-Q filed 2014-11-14.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2014-11-14
- 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $248.35K; Finite-Lived Intangible Asset, Expected Amortization, Year Five as first filed $250.18K.
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $249.11K; Finite-Lived Intangible Asset, Expected Amortization, Year Five as first filed $242.54K.
- 2012-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $242.24K.
- 2011-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $241.93K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five | Finite-Lived Intangible Asset, Expected Amortization, Year Five as first filed |
|---|---|---|
| 2013-12-31 | $248.35K 10-Q · filed 2014-11-14 | $250.18K 10-K · filed 2014-03-31 |
| 2012-12-31 | $249.11K 10-Q · filed 2013-11-14 | $242.54K 10-K · filed 2013-04-01 |
| 2012-06-30 | $242.24K 10-Q/A · filed 2012-09-13 | |
| 2011-12-31 | $241.93K 10-Q · filed 2012-11-14 |